A multiply convergent platform for the synthesis of trioxacarcins.
Many first-line cancer drugs are natural products or are derived from them by chemical modification. The trioxacarcins are an emerging class of molecules of microbial origin with potent antiproliferative effects, which may derive from their ability to covalently modify duplex DNA. All trioxacarcins appear to be derivatives of a nonglycosylated natural product known as DC-45-A2. To explore the potential of the trioxacarcins for the development of small-molecule drugs and probes, we have designed a synthetic strategy toward the trioxacarcin scaffold that enables access to both the natural trioxacarcins and nonnatural structural variants. Here, we report a synthetic route to DC-45-A2 from a differentially protected precursor, which in turn is assembled in just six steps from three components of similar structural complexity. The brevity of the sequence arises from strict adherence to a plan in which strategic bond-pair constructions are staged at or near the end of the synthetic route.
Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA.
Jakub
J
Švenda
Nicholas
N
Hill
Andrew G
AG
Myers
D000478:Alkylation / Q000187:drug effects; D000617:Aminoglycosides / Q000138:chemical synthesis* / Q000737:chemistry* / Q000494:pharmacology; D018906:Antineoplastic Agents, Alkylating / Q000138:chemical synthesis* / Q000737:chemistry* / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000737:chemistry / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D015394:Molecular Structure
D000617:Aminoglycosides; D018906:Antineoplastic Agents, Alkylating; D004273:DNA, Neoplasm; C033790:trioxacarcin
Nature. 1998 Mar 19;392(6673):264-9
9521320
Org Lett. 2004 Sep 16;6(19):3217-9
15355016
Nucleic Acids Res. 2008 Jun;36(10):3508-14
18453630
Org Lett. 2007 Aug 30;9(18):3523-5
17691796
Angew Chem Int Ed Engl. 2004 Feb 27;43(10):1281-3
14991799
J Antibiot (Tokyo). 1990 Mar;43(3):253-8
2324010
Org Lett. 2009 Jun 4;11(11):2437-40
19397300
Chem Biol. 2004 Dec;11(12):1607-17
15610844
J Org Chem. 2002 Nov 15;67(23):8019-33
12423129
Biochemistry. 1993 Aug 17;32(32):8068-74
8347608
J Antibiot (Tokyo). 2004 Dec;57(12):771-9
15745111
Science. 2005 Apr 15;308(5720):395-8
15831754
J Antibiot (Tokyo). 1981 Dec;34(12):1519-24
6895890
J Am Chem Soc. 2008 Dec 31;130(52):17913-27
19053822
J Antibiot (Tokyo). 1981 Dec;34(12):1525-30
6800996
J Am Chem Soc. 2004 Jun 2;126(21):6576-8
15161285
Anal Bioanal Chem. 2008 Feb;390(4):1139-47
18210096
Angew Chem Int Ed Engl. 2008;47(1):48-56
18080276
Org Lett. 1999 Dec 2;1(11):1823-6
10836041
Biochemistry. 1995 Jan 17;34(2):415-25
7819233
Science. 1989 Jan 13;243(4888):187-92
2492114